MRC Epidemiology UnitClinical Epidemiologist
Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life
Current work and interests
Dr Raghib Ali is a Clinical Epidemiologist whose research is focused on the causes, prevention and treatment of diseases including diabetes, heart disease and cancer.
Raghib is the CEO, Chief Investigator and Chief Medical Officer of Our Future Health, the UK’s largest health research study and a Consultant in acute medicine at the Oxford University Hospitals NHS Trust and an Honorary Consultant with the Office for Health Disparities and Improvement
In addition, he is Director and Principal Investigator of the Public Health Research Center and Research Professor at New York University, Abu Dhabi and an Associate Fellow at Green-Templeton College at the University of Oxford
His main research interests are the aetiology and prevention of non-communicable diseases and establishing prospective cohort studies in populations which have not previously been studied. He is the Principal Investigator for the UAE Healthy Future Study, one of the first prospective cohort studies in the Middle East, focusing on risk factors for obesity, diabetes and cardiovascular disease. He previously led studies on cancer aetiology in the UK and India as well as working on the UK Biobank project. He has published over 140 papers with over 80,000 citations and an H-index of 51.
He was awarded an OBE in the Queen’s Birthdays Honours 2022 for services to the NHS and the Covid-19 response and was elected as an Honorary Fellow of the Faculty of Public Health in 2023.
Background and experience
Raghib graduated from the University of Cambridge in 2000 with the award of the John Addenbrookes Prize for Medicine and has since gained postgraduate degrees in Epidemiology and Public Health from the University of Oxford and the London School of Hygiene and Tropical Medicine. He was elected a Fellow of the Royal College of Physicians in 2013.
He completed his clinical training in Acute Medicine and Clinical Pharmacology in the Oxford deanery from 2000 to 2009. He was the Clinical Lecturer in the Department of Clinical Pharmacology from 2004 to 2009 and a Clinical Epidemiologist in the Nuffield Department of Population Health from 2009 to 2017.
He was also the Director of the INDOX (India-Oxford Cancer Research Network) from 2006 to 2015 and a Fellow at Green-Templeton College from 2004 to 2016. In parallel, he was appointed as the founding Director of the Public Health Research Center at New York University in 2014.